Virtual screening de possíveis inibidores da trans-enoil-ACP-redutase de Mycobacterium tuberculosis

Abstract

Tuberculosis is found among the main causes of mortality in the World, although is a neglected disease since it is endemic in developing countries. The main route of therapy of tuberculosis is the inhibition of InhA, enzyme that catalyses the production of mycolic acids, which is a component of bacillus cellular wall. This reaction also is the main point of resistance against TB drugs. In this work proposed the study of InhA enzyme, working specifically in silico modeling of enzyme-ligant interactions. These ligands distinguish themselves between two distinct libraries, one of them containing organic compounds selected by its structural similarity with the enzyme substrate, NADH. Due in vitro and orally activity in murine model against tuberculosis exhibited by the compound pentacianoisoniazideferrate (II), another library, containing the pentacianoferrate II moiety bind to an auxiliary ligand studied against que InhA target. The essays realized using ligand rigid and flexible docking both, although the protein always considered rigid. Both essays had acceptable correlation within its results, regardless the scoring function used. The leading inhibitors structures had in common a high stabilization of ligand-enzyme complex due hydrophobic interactions, something expected due polarity of the enzyme binding site.